Cover Image
市場調查報告書

中東的非侵入式的產前遺傳檢測(NIPT)市場未來展望

Middle East NIPT Market Outlook

出版商 RNCOS E-Services Pvt. Ltd. 商品編碼 319600
出版日期 內容資訊 英文 35 Pages
訂單完成後即時交付
價格
Back to Top
中東的非侵入式的產前遺傳檢測(NIPT)市場未來展望 Middle East NIPT Market Outlook
出版日期: 2014年11月14日 內容資訊: 英文 35 Pages
簡介

全球各國生產女性的平均年齡年年上升。30歲以後結婚,35歲以後生第一胎的案例也很常見。可是,隨著母親的年齡上升,小孩子發生染色體異常的風險增加。為此,無侵入性產前遺傳檢測(NIPT)高變得引人注目。另一方面,中東各國的情況,也牽涉到近親婚姻,及大家族制伴隨的高齡生產的因素。中東各國的NIPT市場潛在規模,估計2013年的階段達到10億9000萬美元。

本報告提供中東的NIPT市場相關分析、檢驗概要和目前技術水準、主要市場促進與阻礙因素、在主要國家的生產數量和遺傳基因疾病的可能性、潛在的市場預測、法規環境與今後的預測、主要企業簡介的資訊彙整,為您概述為以下內容。

第1章 NIPT(非侵入式的產前遺傳檢測)的概要

第2章 唐氏症的風險與高齡生產孩子的關聯性

第3章 中東市場上的檢驗的可利用性

第4章 推動市場要素

  • 生產年齡的上升
  • 血緣關係
  • 唐氏症的發病率高
  • 人們的認識的變化
  • 經濟富餘

第5章 課題

  • 對墮胎的排斥反應
  • 染色體異常、生產前檢驗的認識度低

第6章 中東各國的法規方案

第7章 中東主要國家的市場可能性

  • 沙烏地阿拉伯
  • 以色列
  • 阿拉伯聯合大公國(UAE)
  • 科威特
  • 卡達

第8章 近幾年趨勢

第9章 未來展望

圖表一覽

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄

It"s no longer unusual for women to marry post age 30 or to have their first child at 35 years of age. With the rise in the age of mother, her risk of having a baby suffering from Down"s syndrome increases. This is where NIPT, non-invasive procedures to identify subgroups of mothers who may have a baby with birth defects, come into the picture.

Nowadays, women and men are taking longer to complete their education, establish themselves at work, achieve financial independence and get married. As a result, over the past few years, birth rates among women in their teens or early 20s have been declining, while they"ve been rising among women in their early 40s. Apart from these common factors, issues such as consanguinity and advanced maternal age due to large family size are quite prevalent, especially in the Middle East Countries.

According to our report "Middle East NIPT Market Outlook", the aforementioned factors have led to the emergence of the Middle East as a lucrative market for NIPT, whose total potential for the year 2013 was US$ 1.09 Billion. The report helps shed light on the present scenario in the Middle Eastern countries and elaborates on the role of evolving perception across the region in improving the scope of NIPT.

We have identified key countries within the Middle East which hold the maximum potential for NIPT. These countries include the UAE, Saudi Arabia, Israel, Kuwait and Qatar. In the report, we discuss the various drivers, challenges and regulatory developments that have helped shape the current market. We talk about the contribution of advanced maternal age and consanguinity to the high incidence of Down"s syndrome and its impact on the potential market. For every country, a detailed analysis has been presented in terms of the total number of births, the contribution of high risk mothers within the number of births and the total potential market.

At the end, we have presented recent developments around genetic screening and pregnancy termination that have taken place in the Middle East and their possible impact on the market. The report comes to a conclusion with a future outlook section which emphasizes how with regulatory developments such as Israel"s announcement of making abortions free, the attitudes towards prenatal screening are changing and how it will in turn benefit the NIPT industry.

Table of Contents

1. NIPT - An Introduction

2. Association of Down"s Syndrome Risk to Fetus with Mother"s Age

3. Tests Available in the Middle Eastern Market

4. Market Drivers

  • 4.1 Advanced Maternal Age
  • 4.2 Consanguinity
  • 4.3 High Incidence of Down"s Syndrome
  • 4.4 Changing Perceptions
  • 4.5 Affluence

5. Challenges

  • 5.1 Unacceptability of Termination of Pregnancy
  • 5.2 Unawareness of Chromosomal Anomalies and Prenatal Tests

6. Regulatory Scenario

  • 6.1 Saudi Arabia
  • 6.2 Israel
  • 6.3 UAE
  • 6.4 Kuwait
  • 6.5 Qatar

7. Market Potential in Key Middle East Countries

  • 7.1 Saudi Arabia
  • 7.2 Israel
  • 7.3 UAE
  • 7.4 Kuwait
  • 7.5 Qatar

8. Recent Developments

9. Future Outlook

List of Figures:

  • Figure 1: Percentage of High Risk Births (2013)
  • Figure 2: Global Prevalence of Consanguinity (2009)
  • Figure 3: Probability of Incidence of Down"s syndrome (2003)
  • Figure 4: Saudi Arabia - Number of Births (Thousands), 2012-2018
  • Figure 5: Saudi Arabia - Percentage of Births by Mother"s Risk of Down"s syndrome (%), 2013
  • Figure 6: Saudi Arabia - Potential NIPT Market (Million US$), 2013
  • Figure 7: Israel - Number of Births (Thousands), 2012-2018
  • Figure 8: Israel - Percentage of Births by Mother"s Risk of Down"s syndrome (%), 2013
  • Figure 9: Israel - Potential NIPT Market (Million US$), 2013
  • Figure 10: UAE - Number of Births (Thousands), 2012-2018
  • Figure 11: UAE - Percentage of Births by Mother"s Risk of Down"s syndrome (%), 2013
  • Figure 12: UAE - Potential NIPT Market (Million US$), 2013
  • Figure 13: Kuwait - Number of Births (Thousands), 2012-2018
  • Figure 14: Kuwait - Percentage of Births by Mother"s Risk of Down"s syndrome (%), 2013
  • Figure 15: Kuwait - Potential NIPT Market (Million US$), 2013
  • Figure 16: Qatar - Number of Births (Thousands), 2012-2018
  • Figure 17: Qatar - Percentage of Births by Mother"s Risk of Down"s syndrome (%), 2013
  • Figure 18: Qatar - Potential NIPT Market (Million US$), 2013

List of Tables:

  • Table 1: Comparison of Features of Key NIPT in the Market
  • Table 2: Risk of Down"s syndrome with Rise in Maternal Age
  • Table 3: NIPT Tests Available in Key Countries of the Middle East
  • Table 4: Per Capita National Disposable Income at Current Prices (US$), 2008-2012
  • Table 5: Grounds for Legal Abortion in some Middle Eastern Countries
  • Table 6: Saudi Arabia - Percentage Contribution of Number of Births by Age of Mother (2007 & 2013)
  • Table 7: Israel - Percentage Contribution of Number of Births by Age of Mother (2013)
  • Table 8: UAE - Percentage Contribution of Number of Births by Age of Mother (2008 & 2013)
  • Table 9: Kuwait - Percentage Contribution of Number of Births by Age of Mother (2012 & 2013)
  • Table 10: Qatar - Percentage Contribution of Number of Births by Age of Mother (2009 & 2013)
Back to Top